Department of Neurology

Neurology unit is running in MLB medical college since 2009. Separate Department of Neurology is established  after inauguration of Superspeciality block in 2019. This is only superspeciality teaching Neurology department in Bundelkhand region of central India. Since its inception, department of Neurology is progressing by leaps and bounds. Department of Neurology has one units consists of professor, associate Professor,  assistant Professor and Post DM Senior resident. DM Neurology course is started in 2024 with 5 seats of DM neurology.

      Department of Neurology is running daily OPD with average attendance of 5000 Patients Per month. Sub speciality OPD of movement disorder and epilepsy is scheduled twice a week. Botox clinic is conducted once a month . In Patient Department has average admission of 300 Patients Per month. Neuro electrophysiology lab  has  EEG, EMG NCV machines. Facility of Transcranial magnetic stimulation machine is also available in department. ICMR funded research project on stroke along with number of  other research projects  and postgraduate thesis work are going on in neurology department.  During last 4 years more than 25 Publications are published in national and international Journals.

Faculty position

1. Dr. Arvind Kumar Kankane- MBBS, MD (Medicine), DM( Neurology), MNAMS-Professor and Head – UP MCI No- 42476

2. Dr. Arpit Agarwal  MBBS, MD (Medicine), DM (Neurology)– Assisstant Professor UP MCI-29484

3. Dr Satinder Deswal MBBS, MD(Medicine), DM(Neurology) Assistant Professor DMC-R12327

PUBLICATIONS OF DEPARTMENT OF NEUROLOGY

Publication of the last 5 Years from 2020 to 2025

2020:-

• Dr Arvind Kumar Kankane, Dr. Aradhana Kankane,Vijay Singh. “Effectiveness of Magnesium Sulphate in Term Neonate withPerinatalAsphyxia : An Experience from Tertiary Hospital of Central India”. Sch JApp Med Sci, Jan 2020 : 8(1): 174-177.
• Dr Prakash Gundagatti, Dr. Atul Kumar Pandey , Dr Sareetha AV & Dr. Pramod GR .Study of serum magnesium level in patients ofnewly diagnosed type-2 diabetes mellitus and its effect on glycemic control. International Journal of Advanced Research in Medicine2020, 2(2):133-135
• Juneja, Abhishek; Anand, Kuljeet Singh; Agrawal, Arpit. Owl’s Eye Sign: A Rare Neuroimaging Finding. Indian Journal of Medical Specialities 11(2):p 109-110, Apr–Jun 2020. | DOI: 10.4103/INJMS.INJMS_16_20
• Dr. Abhishek Chaubey, Dr. Jyoti Goyal, Dr. Vipul Mishra,Dr. Paramjeet Singh Bhatia, Dr. Karunesh Prasad Singh. Dr. Utpal Sharma, Dr. Amit Singh, Dr. Rahul Chand: acute fatty liver of pregnancy: case report

2021:-

•  Dr. Arvind Kumar Kankane, Dr. Aradhana Kankane, Dr. Pranjal Mishra. Reversible Neurological Syndrome with COVID-19 : An Experience from Tertiary Hospital of Central India.IOSR Journal of Dental and Medical Sciences (IOSR-JDMS).Volume 20, Issue 2 Ser.10 (February. 2021), 28-31.
• Prakash Gundagatti, Atul Kumar Pandey ,Sareetha AV, Pramod GR. To Study Correlates of thyroid disorder in typeDMPatients.International Journal of Advanced Research in Medicine 2021,3(1) 476-479
• Shweta Pandey, Manish R Patil, Ravi Uniyal,ImranRizvi, Study of Tumefactive Demyelinating Brain Lesion Developing after Administration of Adenovector-Based COVID-19 Vaccine :ACase Report
• Juneja A, Anand KS, Garg J, Agrawal A. Foix-Chavany-Marie Syndrome – A Rare Presentation of Unilateral Opercular Infarction. Neurol India. 2021 Sep-Oct;69(5):1463-1464. doi: 10.4103/0028-3886.329551. PMID: 34747847.

2022:-

• Singh, R., Kankane, A., &Shirol, B. (2022). Prevalence of cardiovascular autonomic neuropathy in type-2 diabetes mellitus and role of corrected QT interval for its diagnosis. European Journal of Molecular and Clinical Medicine, 9(1), 1182-86.

2023:-

• Pandey AK, Kankane A, Patil MR, Agarwal A. Reversible neurological manifestation of dengue virus infection: A case series and short review for clinical practice. IP Indian J Neurosci. 2023;9(3):176-181.
• Arvind kumarkankane ,Atulkumarpandey,PatilmanishRamesh,Manjula. Study of clinical profileand outcome of acute ischemic stroke in young patients: a hospital based cross sectional studyvolume-12 | issue- 09 | september- 2023.
• Dr. Arvind kumar kankane, dr. Atul kumarpandey, dr. Patil manishramesh, dr arpitAgarwal, dr shailjasingh. Studyof association of peripheral neuropathy in chronic kidney disease-a clinico- demographicalstudy volume-12 | issue- 09 | september- 2023
• Sengar NS, Arvind Kankane, Shailja Singh, Nutan Agrawal. Clinical and demographic profile of peripheral neuropathy in chronic kidney disease in tertiary hospital in Bundelkhand region, Central India. Asian J Med Sci. 2023 Nov. 14(11):191-4
• Anshul Jain, Prashant Gupta, Apurva Abhinandan Mittal, Narendra Singh Sengar, Rachna Chaurasia, Neeraj Banoria, Arvind Kankane, Arpita Saxena,  Brijendra, Mrinal Sharma.Long-term quality of life and work ability among severe COVID-19 survivors: A multicenterstudy, Dialogues in Health, Volume 2,2023,100124,

2024:-

• Kankane, Arvind Kumar; Pandey, Atul Kumar; Patil, Manish Ramesh; Agarwal Arpit. Role of Repetitive Transcranial Magnetic Stimulation in Treatment of Fibromyalgia: A Randomized Controlled Trial. Annals of Indian Academy of Neurology 27(2):p 158-164, Mar–Apr 2024.
• Singhal saurabh, Mishra Siddant, Hora Adarsh. PROGNOSTIC IMPORTANCE OF HYPONATREMIA IN ACUTE ST-ELEVATION MYOCARDIAL INFARCTION. Global journal of research article. Volume 13 issue 09, September 2024

2025:-

• Jogi, Hardeep; Kankane, Arvind1; Jain, Vikas,Kumar, Patel G3; Gupta, Preeti4. Dystonia Secondary to Intramedullary Lesion of Spinal Cord: A Case Report. Annals of Indian Academy of Neurology ():10.4103/aian.aian_424_25, December 12, 2025.
• Kankane A, Gupta S, Kankane AK. Impact of long-term antiseizure medications on serum vitamin B12 and folate levels in children with epilepsy in central India. Ann Natl Acad Med Sci (India). 2026;62:54-9.
• Swarna Tripathi, Mohd Zaki Siddique, Arvind Kankane, Atul Pandey. Role of repetitive transcranial magnetic stimulation in treating metabolic syndrome. Asian J Med Sci [Internet]. 2025 Dec. 31 [cited 2026 Jan. 20];17(1):71-6.

S.No.	Titles of Clinical Trial/BE-BE Study Protocols reviewed under the New Drugs and Clinical Trials Rules, 2019 along with protocol number	Brief Summary	Date of EC approval & Current Status	Name Of Sponsor	Publication Status	Whether part of global trial, NCE/Non NCE trial
1.	Protocol Title: A Prospective, Multi- Center, Double blind, Comparative, Active-Controlled, Parallel Group, Randomized Study to Evaluate the Efficacy and Safety of Fixed Dose Combination (FDC) of Pregabalin ER 82.5mg and Polmacoxib 2mg compared to Pregabalin 75 mg and Etoricoxib 60mg in Indian Adult Patients with Chronic Lower Back Pain. HCR/III/POLPRELBP/02/2023	Phase III Study	26/05/2025	Hetero labs Pvt Ltd. Hyderabad	STUDY ONGOING	Non NCE Trial
2.	Protocol Title :- A Phase III, Multicenter, Randomized, Double− blind, Parallel−group clinical trial to compare the Efficacy and Safety of the Cenobamate tablets as adjunctive therapy versus Eslicarbazepine in focal seizures Protocol No.: LCT−04/23, version no. 2.0, dated 20−Sep−24	Phase III Study	27/03/2025	Bajaj Healthcare Limited, 6th floor, Bhoomi Velocity Infotech Park, Thane [W]	STUDY ONGOING	Non NCE Trial
3.	Protocol Title :- “Indian Trial of Tranexamic acid in Spontaneous intracerebral haemorrhage” INTRINSIC TRIAL	Phase II Study	07/02/2024	ICMR	STUDY ONGOING	Non NCE Trial
4.	Protocol Title:               A prospective, multicentric, randomized, double-blind, parallel, phase IV study to assess the safety  and  efficacy  of  TycamzziTM (sovateltide) in patients with acute cerebral ischemic stroke. Study Protocol No.: Sovateltide/CT- 4.1/2022	Phase IV Study	30/11/2023	Pharmazz India Pvt. Ltd. Greater Noida- U.P	STUDY ONGOING	Non NCE Trial
5.	A Phase III, Multi-centric, Prospective, Randomized, Parallel study to Evaluate the Efficacy and Safety of Molnupiravir Capsule in Adult Indian Patients with Mild COVID-19 HCR/III/MOLCOV/04/2021-01 Version 3.0 dated 07 MAY 2021	Phase III Study	14/05/2021	Hetero labs Pvt Ltd. Hyderabad	PUBLISHED	Non NCE Trial